Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in First-Line APL Consolidation
NCT00003934Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1999
- Primary completion
- Nov 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by National Cancer Institute. Started Jun 1999; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00003934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003934.